Nova Eye Medical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Tom Spurling
Chief executive officer
AU$310.6k
Total compensation
| CEO salary percentage | 61.4% |
| CEO tenure | 2.9yrs |
| CEO ownership | 0.3% |
| Management average tenure | 5yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -AU$11m |
| Sep 30 2022 | n/a | n/a | -AU$9m |
| Jun 30 2022 | AU$311k | AU$191k | -AU$7m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | n/a | n/a | -AU$6m |
| Sep 30 2021 | n/a | n/a | -AU$5m |
| Jun 30 2021 | AU$72k | AU$66k | -AU$4m |
| Dec 31 2020 | n/a | n/a | -AU$9m |
| Sep 30 2020 | n/a | n/a | -AU$10m |
| Jun 30 2020 | n/a | n/a | -AU$10m |
| Dec 31 2019 | n/a | n/a | -AU$6m |
| Sep 30 2019 | n/a | n/a | -AU$6m |
| Jun 30 2019 | AU$328k | AU$306k | -AU$7m |
| Mar 31 2019 | n/a | n/a | -AU$7m |
| Dec 31 2018 | n/a | n/a | -AU$6m |
| Sep 30 2018 | n/a | n/a | -AU$6m |
| Jun 30 2018 | AU$329k | AU$300k | -AU$5m |
| Mar 31 2018 | n/a | n/a | -AU$5m |
| Dec 31 2017 | n/a | n/a | -AU$5m |
| Sep 30 2017 | n/a | n/a | -AU$3m |
| Jun 30 2017 | AU$361k | AU$300k | -AU$894k |
Compensation vs Market: Tom's total compensation ($USD208.99K) is below average for companies of similar size in the US market ($USD740.57K).
Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.
CEO
Tom Spurling (61 yo)
2.9yrs
Tenure
AU$310,578
Compensation
Mr. Thomas H. Spurling, also known as Tom, BSc (Hons), Ph D., FRACI, FTSE, AM is Executive Director at Nova Eye Medical Limited since August 31, 2020 and serves as its Managing Director. Mr. Spurling was C...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 22yrs | AU$220.14k | no data | |
| MD & Executive Director | no data | AU$310.58k | 0.29% $ 89.0k | |
| Chief Financial Officer | no data | no data | no data | |
| Vice President of Global Operations | no data | no data | no data | |
| Investor Relations | no data | no data | no data | |
| Head of Marketing | no data | no data | no data | |
| Chief Medical Officer | 4.8yrs | no data | no data | |
| President of Ellex iTrack | 5yrs | no data | no data | |
| Group Financial Controller & Global Finance Manager | 7.7yrs | no data | no data | |
| Company Secretary | 3.1yrs | no data | no data | |
| Vice President of Global Service | no data | AU$143.97k | no data | |
| Advisor to the Board | no data | AU$243.97k | no data |
5.0yrs
Average Tenure
65yo
Average Age
Experienced Management: ELXM.F's management team is seasoned and experienced (5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 22yrs | AU$220.14k | no data | |
| MD & Executive Director | 2.9yrs | AU$310.58k | 0.29% $ 89.0k | |
| Independent Director | 10.2yrs | AU$44.00k | 0.63% $ 192.5k | |
| Non Executive Director | 5yrs | AU$41.70k | 0.011% $ 3.2k | |
| Non-Executive Director | less than a year | no data | 0.29% $ 89.7k |
5.0yrs
Average Tenure
61yo
Average Age
Experienced Board: ELXM.F's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/07/23 06:43 |
| End of Day Share Price | 2023/04/25 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nova Eye Medical Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tanushree Jain | Bell Potter |
| Michael Youlden | MST Financial Services Pty Limited |
| Robin Morgan | Taylor Collison Limited |